Intrinsic, pro-apoptotic effects of IGFBP-3 on breast cancer cells are reversible: Involvement of PKA, Rho, and ceramide

Frontiers in Endocrinology

Volumn 2, Issue MAY, 2010, Pages

  Perks, Claire M ^a   Burrows, Carla ^a   Holly, Jeff M P ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Ceramide; IGF independent; IGFBP 3; PKA; Rho

Indexed keywords

EID: 84874219867     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2011.00013     Document Type: Article

References (52)

1. Berman, A. E., Kozlova, N. I., and Morozevich, G. E. (2003). Integrins: structure and signaling. Biochemistry Mosc. 68,1284-1299.
2. Bishop, A. L, and Hall, A. (2000). Rho GTPases and their effector proteins. Biochem. J. 348(Pt 2), 241-255.
3. Bollinger, C. R., Teichgraber, V., and Gulbins, E. (2005). Ceramide-enriched membrane domains. Biochim. Biophys. Acta 1746, 284-294.
4. Brown, N. H. (2000). An integrin chicken and egg problem: which comes first, the extracellular matrix or the cytoskeleton? Curr. Opin. Cell Biol. 12, 629-633.
5. Burrows, C, Holly, J. M., Laurence, N. J., Vernon, E. G., Carter, J. V., Clark, M. A., Mclntosh, J., McCaig, C, Winters, Z. E., and Perks, C. M. (2006). Insulin-like growth factor binding protein 3 has opposing actions on malignant and nonmalignant breast epithelial cells that are each reversible and dependent upon cholesterolstabilized integrin receptor complexes. Endocrinology 147, 3484-3500.
6. Cohen, P., Rajah, R., Rosenbloom, J., and Herrick, D. J. (2000). IGFBP-3 mediates TGF-betal-induced cell growth in human airway smooth muscle cells. Am. J. Physiol. Lung Cell Mot Physiol. 278, L545-L551.
7. Cuvillier, O., Pirianov, G., Kleuser, B., Vanek, P. G., Coso, O. A., Gutkind, S., and Spiegel, S. (1996). Suppression of ceramide-mediated programmed cell death by sphingosine- 1-phosphate. Nature 381, 800-803.
8. Fanayan, S., Firth, S. M., Butt, A. J., and Baxter, R. C. (2000). Growth inhibition by insulin-like growth factorbinding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta) and the type II TGF-beta receptor. Biol Chem. 275, 39146-39151.
9. Gill, Z. P., Perks, C. M., Newcomb, P. V., and Holly, J. M. (1997). Insulinlike growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner. Biol Chem. 272, 25602-25607.
10. Granata, R., Trovato, L., Garbarino, G., Taliano, M., Ponti, R., Sala, G., Ghidoni, R., and Ghigo, E. (2004). Dual effects of IGFBP-3 on endothelial cell apoptosis and survival: involvement of the sphingolipid signaling pathways. FASEB J. 18, 1456-1458.
11. Grassme, H., Jekle, A., Riehle, A., Schwarz, H., Berger, J., Sandhoff, K., Kolesnick, R., and Gulbins, E. (2001). CD95 signaling via ceramide-rich membrane rafts. Biol Chem. 276, 20589-20596.
12. Hollowood, A. D., Lai, T., Perks, C. M., Newcomb, P. V., Alderson, D., and Holly, J. M. (2000). IGFBP-3 prolongs the p53 response and enhances apoptosis following UV irradiation. Int.]. Cancer 88, 336-341.
13. Hollowood, A. D., Stewart, C. E., Perks, C. M., Pell, J. M., Lai, T., Aiderson, D., and Holly, J. M. (2002). Evidence implicating a mid-region sequence of IGFBP-3 in its specific IGF-independent actions. Cell. Biochem. 86, 583-589.
14. Hotchin, N. A., and Hall, A. (1995). The assembly of integrin adhesion complexes requires both extracellular matrix and intracellular rho/rac GTPases. Cell Biol 131, 1857-1865.
15. Howe, A. K. (2004). Regulation of actinbased cell migration by cAMP/PKA. Biochim. Biophys. Acta 1692, 159-174.
16. Ingermann, A. R., Yang, Y. E, Han, J., Mikami, A., Garza, A. E., Mohanraj, L., Fan, L., Idowu, M., Ware, J. L, Kim, H. S., Lee, D.-Y, and Oh, Y (2010). Identification of a novel cell death receptor mediating IGFBP-3- induced anti-tumor effects in breast and prostate cancer. Biol Chem. 285, 30233-30246.
17. Jones, J. I., and Clemmons, D. R. (1995). Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16, 3-34.
18. Jones, J. I., Gockerman, A., Busby, W. H., Jr., Wright, G., and Clemmons, D. R. (1993). Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg- Gly-Asp sequence. Proc. Nail. Acad. Sci. U.S.A 90, 10553-10557.
19. Kansra, S., Ewton, D. Z., Wang, J., and Friedman, E. (2000). IGFBP-3 mediates TGF beta 1 proliferative response in colon cancer cells. Int. J. Cancer 87, 373-378.
20. Leal, S. M., Liu, Q., Huang, S. S., and Huang, J.S. (1997). The type Vtransforming growth factor beta receptor is the putative insulin-like growth factor-binding protein 3 receptor. Biol Chem. 272, 20572-20576.
21. Lee, K. W, Liu, B., Ma, L, Li, H., Bang, P., Koeffler, H. P., and Cohen, P. (2004). Cellular internalization of insulinlike growth factor binding protein-3: distinct endocytic pathways facilitate re-uptake and nuclear localization. J. Biol Chem. 279, 469-476.
22. Leve, E, de Souza, W., and Morgado- Diaz, J. A. (2008). A cross-link between protein kinase A and Rhofamily GTPases signaling mediates cell-cell adhesion and actin cytoskeleton organization in epithelial cancer cells. J. Pharmacol Exp. Ther. 327, 777-788.
23. Levin, A. M., Murase, K., Jackson, P. J., Flinspach, M. L., Poulos, T. L., and Weiss, G. A. (2007). Double barrel shotgun scanning of the caveolin-1 scaffolding domain. ACS Chem. Biol 2,493-500.
24. Liu, B., Lee, H. Y., Weinzimer, S. A., Powell, D. R., Clifford, J. L, Kurie, J. M., and Cohen, P. (2000). Direct functional interactions between insulinlike growth factor-binding protein- 3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis. J. Biol Chem. 275, 33607-33613.
25. Martin, J. L., and Jambazov, S. (2006). Insulin-like growth factor binding protein-3 in extracellular matrix stimulates adhesion of breast epithelial cells and activation of p44/42 mitogen-activated protein kinase. Endocrinology 147, 4400-4409.
26. Martin, J. L., Lin, M. Z., McGowan, E. M., and Baxter, R. C. (2009). Potentiation of growth factor signaling by insulin-like growth factor-binding protein-3 in breast epithelial cells requires sphingosine kinase activity. J. Biol Chem. 284, 25542-25552.
27. Martin, J. L., and Pattison, S. L. (2000). Insulin-like growth factor binding protein-3 is regulated by dihydrotestosterone and stimulates deoxyribonucleic acid synthesis and cell proliferation in LNCaP prostate carcinoma cells. Endocrinology 141, 2401-2409.
28. Martin, J. L., Weenink, S. M., and Baxter, R. C. (2003). Insulin-like growth factor-binding protein-3 potentiates epidermal growth factor action in MCF-10A mammary epithelial cells. Involvement of p44/42 and p38 mitogen-activated protein kinases. J. Biol Chem. 278,2969-2976.
29. McCaig, C, Fowler, C. A., Laurence, N. J., Lai, T., Savage, P. B., Holly, J. M., and Perks, C. M. (2002a). Differential interactions between IGFBP- 3 and transforming growth factorbeta (TGF-beta) in normal vs cancerous breast epithelial cells. Br. J. Cancer 86, 1963-1969.
30. McCaig, C, Perks, C. M., and Holly, J. M. (2002b). Intrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectin. Cell Sci. 115,4293-4303.
31. McCaig, C, Perks, C. M., and Holly, J. M. (2002c). Signalling pathways involved in the direct effects of IGFBP-5 on breast epithelial cell attachment and survival. Cell. Biochem. 84, 784-794.
32. Mclntosh, J., Dennison, G., Holly, J. M., Jarrett, C, Frankow, A., Foulstone, E. J., Winters, Z. E., and Perks, C. M. (2010). IGFBP-3 can either inhibit or enhance EGF-mediated growth of breast epithelial cells dependent upon the presence of fibronectin. Biol Chem. 28, 38788-38800.
33. Oda, K., Hori, S., Itoh, H., Osamura, R. Y., Tokuda, Y, Kubota, M., and Tajima, T. (1992). Immunohistochemical study of transforming growth factor beta, fibronectin, and fibronectin receptor in invasive mammary carcinomas. Acta Pathol Jpn. 42, 645-650.
34. Oh, Y, Gucev, Z., Ng, L., Muller, H. L, and Rosenfeld, R. G. (1995). Antiproliferative actions of insulinlike growth factor binding protein (IGFBP)-3 in human breast cancer cells. Prog. Growth Factor Res. 6, 503-512.
35. Oh, Y, Muller, H. L., Pham, H., and Rosenfeld, R. G. (1993). Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. Biol Chem. 268,26045-26048.
36. Pellegrin, S., and Mellor, H. (2008). Rho GTPase activation assays. Curr. Protoc. Cell Biol Chapter 14, Unit 14.8.
37. Perks, C. M, Vernon, E. G., Clark, M. A., Burrows, C, and Holly, J. M. P. (2004)."IGF-independent actions of IGFBP-3 involve cholesterol stabilised complexes and modulation of sphingolipid metabolites," in Proceedings of the 86th Annual Meeting of the American Endocrine Society, New Orleans, P3-P94.
38. Perks, C. M., Bowen, S., Gill, Z. P., Newcomb, P. V., and Holly, J. M. (1999a). Differential IGF-independent effects of insulin-like growth factor binding proteins (1-6) on apoptosis of breast epithelial cells. J. Cell Biochem. 75, 652-664.
39. Perks, C. M., Newcomb, P. V., Norman, M. R., and Holly, J. M. (1999b). Effect of insulin-like growth factor binding protein-1 on integrin signalling and the induction of apoptosis in human breast cancer cells. J. Mol Endocrinol 22, 141-150.
40. Perks, C. M., and Holly, J. M. (2003). The insulin-like growth factor (IGF) family and breast cancer. Breast Dis. 18,45-60.
41. Rajah, R., Valentinis, B., and Cohen, P. (1997). Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-betal on programmed cell death through a p53- and IGF-independent mechanism. J. Biol Chem. 272, 12181-12188.
42. Ren, X. D., and Schwartz, M. A. (2000). Determination of GTP loading on Rho. Meth. Enzymol 325,264-272.
43. Ridley, A. J. (2001). Rho family proteins: coordinating cell responses. Trends Cell Biol, 11, 471-477.
44. Ridley, A. J., and Hall, A. (1992). The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70, 389-399.
45. Schatzmann, E, Marlow, R., and Streuli, C. H. (2003). Integrin signaling and mammary cell function. J. Mammary Gland Biol Neoplasia 8, 395-408.
46. Schedlich, L. J., Young, T. E, Firth, S. M., and Baxter, R. C. (1998). Insulinlike growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J. Biol Chem. 273, 18347-18352.
47. Schutt, B. S., Langkamp, M., Rauschnabel, U., Ranke, M. B., and Elmlinger, M. W (2004). Integrin-mediated action of insulin-like growth factor binding protein-2 in tumor cells. Mol Endocrinol 32, 859-868.
48. Schwartz, M. A., Schaller, M. D., and Ginsberg, M. H. (1995). Integrins: emerging paradigms of signal transduction. Annu. Rev. Cell Dev. Biol 11,549-599.
49. Singh, B., Charkowicz, D., and Mascarenhas, D. (2004). Insulin-like growth factor-independent effects mediated by a C-terminal metalbinding domain of insulin-like growth factor binding protein-3. J. Biol Chem. 279, 477-487.
50. van Blitterswijk, W. J., van der Luit, A. H., Veldman, R. J., Verheij, M., and Borst, J. (2003). Ceramide: second messenger or modulator of membrane structure and dynamics? Biochem.J. 369, 199-211.
51. Williams, A. C, Collard, T. J., Perks, C. M., Newcomb, P., Moorghen, M., Holly, J. M., and Paraskeva, C. (2000). Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cells. Cancer Res. 60, 22-27.
52. Yamada, K. M., and Miyamoto, S. (1995). Integrin transmembrane signaling and cytoskeletal control. Curr. Opin. Cell Bid. 7, 681-689.